Browse by Tags

As we inch toward the end of 2011, a look back over the past few months shows a great deal of progress in JDRF’s efforts toward curing, treating, and preventing type 1 diabetes (T1D) and its complications. Check out the latest key advances from the first quarter of fiscal year 2012 (July through...

Researchers from the Salk Institute have identified molecular switches that regulate islet beta cell survival and insulin production. These findings could help lead to development of new diabetes drugs. The JDRF-funded Salk researchers, led by Dr. Marc Montminy, focused on glucagon-like peptide-1 (GLP...

Recent findings from a study on beta cell regeneration may open up doors to new therapies for people with type 1 diabetes. JDRF-funded researchers in Israel found for the first time that a high rate of glucose metabolism - the process in which glucose is converted into energy - prompts existing insulin...

For researchers focused on regenerating insulin-producing beta cells, one area of interest has been better understanding how and why these cells increase in pregnant women. Recently, JDRF-funded researchers, led by Dr. Michael German of the University of California San Francisco, have discovered that...

Results of a JDRF-funded study reveal beta cells - cells that produce insulin –can replicate in newly diagnosed patients. These findings suggest that in the future, these mechanisms could be harnessed to restore or maintain beta cell mass in individuals with type 1 diabetes. The findings are published...

JDRF-funded researchers led by Dr. Pedro Herrera at the University of Geneva in Switzerland have shown that “alpha cells” in the pancreas – specialized cells that do not produce insulin – can spontaneously convert into insulin-producing beta cells. While these changes took place...